Bell Potter

S&W Announces First Quarter Fiscal 2024 Financial Results

Retrieved on: 
Thursday, November 9, 2023
IPO, Sorghum, Shell, S&W, SG, EBITDA, Net, Chewy (company), Disclosure, GAAP, Acquisition, Research, Bank statement, Double team, Interest, COVID, Bell Potter, Partnership, Retirement, Benchmarking, Depreciation, Rationalization, Table, Series, Cryptocurrency, Video game, Security (finance), Coal, Reinsurance, Real estate, Bookkeeping, Bank, A2, Alfalfa

Revenue for the first quarter of fiscal 2024 was $16.4 million, a 17.3% decrease compared to the first quarter of fiscal 2023.

Key Points: 
  • Revenue for the first quarter of fiscal 2024 was $16.4 million, a 17.3% decrease compared to the first quarter of fiscal 2023.
  • Double TeamTM sorghum revenue was $0.5 million in the first quarter of fiscal 2024 compared to $0.0 million in the first quarter of fiscal 2023.
  • GAAP gross profit margin for the first quarter of fiscal 2024 was 30.5%, an improvement from 22.7% in the first quarter of fiscal 2023.
  • Operating expenses were $7.9 million for the first quarter of fiscal 2024, which is consistent with operating expenses for the first quarter of fiscal 2023.

S&W Announces Fiscal 2023 Financial Results

Retrieved on: 
Wednesday, September 27, 2023
Rationalization, IPO, Table, Marketing, GAAP, Grain, Interest, Genetics, Retirement, Acquisition, DeKalb Genetics Corporation, Research, KWS Saat, Germination, Biofuel, Double team, Shell, Disclosure, Monsanto, S&W, Depreciation, Sorghum, Bell Potter, Chewy (company), Partnership, SG, Bank statement, COVID, Sale, EBITDA, Series, CIBC, MENA, Benchmarking, LATAM, Cryptocurrency, Security (finance), Management, Agriculture, Risk management, Bookkeeping, Bank, A2, Camelina, Genetically modified wheat, Soybean, Double

LONGMONT, Colo., Sept. 27, 2023 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) today announced financial results for the fiscal year ended June 30, 2023.

Key Points: 
  • LONGMONT, Colo., Sept. 27, 2023 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) today announced financial results for the fiscal year ended June 30, 2023.
  • Double Team™ sorghum revenue was $6.5 million in fiscal 2023, compared to $2.4 million in fiscal 2022.
  • Total revenue for fiscal 2023 was $73.5 million, compared to total revenue for fiscal 2022 of $71.4 million.
  • Adjusted EBITDA (see Table B) for fiscal 2023 was $(9.3) million, compared to adjusted EBITDA of $(23.6) million for fiscal 2022.

FiscalNote to Present at Upcoming Investor Conferences

Retrieved on: 
Tuesday, September 5, 2023
Professional Services, Data Management, Technology, Software, Consulting, Artificial Intelligence, Bell, Software as a service, Policy, New York Hilton Midtown, AEST, Citigroup, FiscalNote, Lotte New York Palace Hotel, Conference, NYSE, Bell Potter, Cryptocurrency, Hotel

FiscalNote will participate virtually.

Key Points: 
  • FiscalNote will participate virtually.
  • Northland Capital Markets Institutional Investor Conference 2023 - Tuesday, September 19, 2023.
  • The conference is virtual.
  • For more information about the conferences, please contact representatives at Citi, H.C. Wainwright, Bell Potter, and Northland Capital.

S&W Looks to Unlock Value of International Operations

Retrieved on: 
Thursday, May 11, 2023
Disclosure, Stevia, International, IPO, Bell Potter, S&W, Audit, Camelina

LONGMONT, Colo., May 11, 2023 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW), a global agricultural company, today announced that its Board of Directors is evaluating potential avenues to unlock what the Company sees as unrecognized value in its international operations, which are headquartered within the Company's Australian subsidiary.

Key Points: 
  • LONGMONT, Colo., May 11, 2023 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW), a global agricultural company, today announced that its Board of Directors is evaluating potential avenues to unlock what the Company sees as unrecognized value in its international operations, which are headquartered within the Company's Australian subsidiary.
  • Mark Wong, CEO, commented: "As part of the overall review of our business commenced last May, we have been looking to maximize value for shareholders through our primary business units: US, International, Camelina and Stevia.
  • Our Australian team has been dedicated to improving and optimizing our international operations over the past several years, and we believe they have created substantial value that is currently not being recognized by the broader markets.
  • We believe now is the right time for us to conduct an accelerated review of our international operations, with a view towards evaluating potential strategic opportunities that could unlock unrecognized value for the benefit of all our stakeholders."

BEACON ANNOUNCES ROBERT POTTER AS CFO

Retrieved on: 
Thursday, September 29, 2022
CFO, Blackstone, Engineering, JPMorgan Chase, BofA Securities, Paul Tudor Jones, Goldman Sachs, Head, Investment, Bank, Shell, Credit Suisse, Technology, Finance, Risk management, Solution, Uncertainty, FP, Research, PIMCO, Bell Potter, Beacon

NEW YORK, Sept. 29, 2022 /PRNewswire/ -- Beacon Platform, the premier cloud-native platform for financial market innovation, has appointed Robert Potter as Chief Financial Officer (CFO). Potter has over thirteen years of experience in finance and joins Beacon Platform having recently served as Head of Financial Planning & Analysis (FP&A) for financial market intelligence company AlphaSense. Potter's experience also includes leading FP&A for Morgan Stanley, Credit Suisse, and Tudor Investments.

Key Points: 
  • NEW YORK, Sept. 29, 2022 /PRNewswire/ -- Beacon Platform , the premier cloud-native platform for financial market innovation, has appointed Robert Potter as Chief Financial Officer (CFO).
  • Potter has over thirteen years of experience in finance and joins Beacon Platform having recently served as Head of Financial Planning & Analysis (FP&A) for financial market intelligence company AlphaSense.
  • I'm delighted to bring my experience to the company," said Robert (Rob) Potter.
  • Potter becomes Beacon's CFO at a time when the company is growing in multiple dimensions, including operations, engineering, and sales.

FiscalNote to Present at Upcoming Investor Conferences

Retrieved on: 
Friday, September 2, 2022
Technology, Finance, Security, Fintech, Banking, Accounting, Professional Services, Software, Data Management, CEO, Technology, NYSE, AEST, CO, Policy, CQ, Software as a service, Bell Potter, Jefferies, Citigroup, Conference, HKT, Bell, Q&A, AI, Management, FiscalNote, Equilibrium, Technology, Finance, Security, Fintech, Banking, Accounting, Professional Services, Software, Data Management

Chairman, CEO, & Co-founder Tim Hwang and Chief Financial Officer & Chief Investment Officer Jon Slabaugh will present an overview of FiscalNote followed by a Q&A session.

Key Points: 
  • Chairman, CEO, & Co-founder Tim Hwang and Chief Financial Officer & Chief Investment Officer Jon Slabaugh will present an overview of FiscalNote followed by a Q&A session.
  • Chairman, CEO, & Co-founder Tim Hwang, Chief Financial Officer & Chief Investment Officer Jon Slabaugh, and President & Chief Operating Officer Josh Resnik will present an overview of FiscalNote followed by a Q&A session.
  • Since 2013, FiscalNote has pioneered technology that delivers mission-critical insights and the tools to turn them into action.
  • To learn more about FiscalNote and its family of brands, visit FiscalNote.com and follow @FiscalNote.

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

Retrieved on: 
Monday, April 4, 2022
Health, Genetics, Other Health, Research, Science, Pharmaceutical, Biotechnology, Risk, Soarin' Eagle, Form 10-K, Therapy, Conditional sentence, Degenerative disease, DNA, Fermentation, Forward-looking statement, Synthetic biology, Canaccord Genuity, K-12, China Biologic Products, Bell Potter, NYSE, Annual report, Bacteria, LBP, SEC, Biotechnology, Program, Decision-making, CEO, Health, MAP, Senior, Agriculture, ASX, Australian Securities Exchange, Lupus, U.S. Securities and Exchange Commission, COVID-19, Computer, List of life sciences, IPO, Food, Disease, Partnership, Dietary supplement, Antibiotics, Ginkgo, MICROBA LIFE SCIENCES, GINKGO BIOWORKS

Microba Life Sciences (ASX: MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a partnership to identify single-strain, live bacteria product (LBP) candidates against autoimmune diseases.

Key Points: 
  • Microba Life Sciences (ASX: MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a partnership to identify single-strain, live bacteria product (LBP) candidates against autoimmune diseases.
  • Microba Life Sciences plans to launch its Initial Public Offering (IPO) on the Australian Securities Exchange (ASX) on April 5.
  • In connection with the partnership, Ginkgo is investing $3.5 million USD in Microba.
  • Microba Life Sciences is a precision microbiome company driving the discovery and development of novel therapeutics for major chronic diseases to improve human health.